Immunoguide® Enzyme immunoassay (ELISA) test kit for the determination of free Trastuzumab (Herceptin®, Herclon®) in serum and plasma.<br><br>
Trastuzumab (trade name Herceptin®, Herclon®) is a recombinant DNA-derived humanized monoclonal antibody that selectively targets the extracellular domain of the human epidermal growth factor receptor 2 protein (HER2). The antibody is an IgG1 kappa that contains human framework regions with the complementarity-determining regions of a murine anti p185 HER2 antibody that binds to HER2. Trastuzumab blood concentrations throughout the dosing interval expected to be remaining above those considered necessary for anticancer activity.<br><br>
In this context, identification of biomarkers for (non-)response and risk factors for adverse drug reactions that might be related to serum concentrations and maintaining the effective concentration of Trastuzumab in order to potentially avoid some side effects with a reliable method might be beneficial. For research use only, not for use in diagnostic procedures.
- Assay Description:
- 60 min. incubation (RT) + 30 min. (RT) + 20 min. (RT) = 1 hour, 50 min. total incubation time
- Catalog number:
- TM09013
- configuration:
- 96 Determinations, 12x8 removable strips
- controls:
- None provided
- design:
- Enzyme immunoassay (ELISA) technique
- FDA Status:
- For research use only, not for use in diagnostic procedures
- MSDS:
- Available upon request
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Protocol:
- Sample types:
- Serum and plasma
- Sample volume:
- 10 µL
- standards:
- 5 standards, ready to use
- Standard range:
- 0 / 6 - 200 ng/mL
- storage:
- 2 - 8 °C
- sensitivity:
- 5 ng/mL
- Species:
- Human
- Products related:
- Anti-Trastuzumab (Herceptin®) ELISA
Trastuzumab (Herceptin®) (mAb-based) ELISA - Additional info:
